Fig 4. Meta-analysis of the 6-month PFS rates in the PD-1 antibody monotherapy groups and the other groups.
The six-month PFS rate was greater among patients who received PD-1 antibodies than among those who received other treatments.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.